iCAD receives AERB approval for Xoft System in India
iCAD announced that its Xoft Axxent Electronic Brachytherapy, or eBx, System has received an Atomic Energy Regulatory Board, or AERB, Type Approval for use in India. The approval affirms that the system conforms to established safety standards and makes the full suite of the company's electronic brachytherapy products available to clinicians and patients across the country. The Omega Hospitals is the first site to adopt the Xoft System in India. Omega Hospitals is an integrated healthcare delivery system providing more than 89,500 patient care visits annually. Hyderabad will be utilizing the Xoft System for the treatment of early-stage breast cancer and gynecological cancers. The Xoft System is FDA cleared, CE marked and licensed in a growing number of countries for the treatment of cancer anywhere in the body. The system utilizes a proprietary, miniaturized x-ray source to deliver precise radiation treatment directly to a cancerous area while sparing surrounding healthy tissue. The system requires only minimal shielding and therefore does not require construction investment.